| Revisiting the role of ABC transporters in multidrug-resistant cancer RW Robey, KM Pluchino, MD Hall, AT Fojo, SE Bates, MM Gottesman Nature Reviews Cancer 18 (7), 452-464, 2018 | 1388 | 2018 |
| Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes DW Shen, LM Pouliot, MD Hall, MM Gottesman Pharmacological reviews 64 (3), 706-721, 2012 | 998 | 2012 |
| Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19 RT Eastman, JS Roth, KR Brimacombe, A Simeonov, M Shen, S Patnaik, ... ACS central Science 6 (5), 672-683, 2020 | 900 | 2020 |
| The discovery and development of cisplatin RA Alderden, MD Hall, TW Hambley Journal of chemical education 83 (5), 728, 2006 | 724 | 2006 |
| Platinum (IV) antitumour compounds: their bioinorganic chemistry MD Hall, TW Hambley Coordination Chemistry Reviews 232 (1-2), 49-67, 2002 | 722 | 2002 |
| The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy MD Hall, M Okabe, DW Shen, XJ Liang, MM Gottesman Annu. Rev. Pharmacol. Toxicol. 48, 495-535, 2008 | 599 | 2008 |
| Basis for design and development of platinum (IV) anticancer complexes MD Hall, HR Mellor, R Callaghan, TW Hambley Journal of medicinal chemistry 50 (15), 3403-3411, 2007 | 513 | 2007 |
| Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes MD Hall, KA Telma, KE Chang, TD Lee, JP Madigan, JR Lloyd, ... Cancer research 74 (14), 3913-3922, 2014 | 352 | 2014 |
| Collateral sensitivity as a strategy against cancer multidrug resistance KM Pluchino, MD Hall, AS Goldsborough, R Callaghan, MM Gottesman Drug Resistance Updates 15 (1-2), 98-105, 2012 | 336 | 2012 |
| Cisplatin is retained in the cochlea indefinitely following chemotherapy AM Breglio, AE Rusheen, ED Shide, KA Fernandez, KK Spielbauer, ... Nature communications 8 (1), 1654, 2017 | 317 | 2017 |
| Toward a Better Understanding of the Complexity of Cancer Drug Resistance MM Gottesman, O Lavi, MD Hall, JP Gillet Pharmacology and Toxicology 56, 2016, 2015 | 317 | 2015 |
| Is resistance useless? Multidrug resistance and collateral sensitivity MD Hall, MD Handley, MM Gottesman Trends in pharmacological sciences 30 (10), 546-556, 2009 | 306 | 2009 |
| Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells H Sarin, AS Kanevsky, H Wu, KR Brimacombe, SH Fung, AA Sousa, ... Journal of translational medicine 6, 1-15, 2008 | 301 | 2008 |
| Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications P Kannan, C John, SS Zoghbi, C Halldin, MM Gottesman, RB Innis, ... Clinical Pharmacology & Therapeutics 86 (4), 368-377, 2009 | 223 | 2009 |
| Fluorescence polarization assays in high-throughput screening and drug discovery: a review MD Hall, A Yasgar, T Peryea, JC Braisted, A Jadhav, A Simeonov, ... Methods and Applications in Fluorescence 4 (2), 022001, 2016 | 219 | 2016 |
| Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance G Szakács, MD Hall, MM Gottesman, A Boumendjel, R Kachadourian, ... Chemical reviews 114 (11), 5753-5774, 2014 | 211 | 2014 |
| Synthesis, activity, and pharmacophore development for isatin-β-thiosemicarbazones with selective activity toward multidrug-resistant cells MD Hall, NK Salam, JL Hellawell, HM Fales, CB Kensler, JA Ludwig, ... Journal of medicinal chemistry 52 (10), 3191-3204, 2009 | 206 | 2009 |
| Manganese Transport and Trafficking: Lessons Learned from Saccharomyces cerevisiae VC Culotta, M Yang, MD Hall Eukaryotic cell 4 (7), 1159-1165, 2005 | 203 | 2005 |
| The cellular distribution and oxidation state of platinum (II) and platinum (IV) antitumour complexes in cancer cells MD Hall, CT Dillon, M Zhang, P Beale, Z Cai, B Lai, APJ Stampfl, ... JBIC Journal of Biological Inorganic Chemistry 8, 726-732, 2003 | 195 | 2003 |
| The “specific” P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2) P Kannan, S Telu, S Shukla, SV Ambudkar, VW Pike, C Halldin, ... ACS chemical neuroscience 2 (2), 82-89, 2011 | 191 | 2011 |
Anton SimeonovNational Institutes of HealthVerified email at mail.nih.gov
